In addition, indirect evidence supports the role of TYK2 signaling in leukemogenesis; inactivation of TYK2 in mice was shown to lead to the development of leukemia and lymphoma, plausibly resulting from the impaired immune defense against tumor cells [93]. Here, TYK2 is linked to lymphoma.